Where are the best risk-adjusted returns today: hospital consolidation, specialty care networks, diagnostics at scale, pharma services and local supply resilience, or the tech and data layer that drives throughput and monetisation?
This session takes an operator’s perspective from Mayapada and brings it together with investors deploying capital across the region—Quadria on the ground in Southeast Asia and Indonesia, Novo Holdings building portfolios across China, India and SEA, and CBC expanding non-dilutive, royalty- and revenue-backed financing for healthcare companies. Expect a practical debate on what’s investable now, how to diligence scalability (unit economics, integration, talent, governance), and the realistic exit pathways in Indonesia and the wider Southeast Asian corridor.
